Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study

被引:5
|
作者
Lu, Lanyu [1 ]
Liu, Bowei [2 ]
Yin, Fuzai [2 ]
机构
[1] Hebei Med Univ, Dept Endocrinol & Metab Dis, Shijiazhuang, Hebei, Peoples R China
[2] First Hosp Qinhuangdao, Dept Endocrinol, Qinhuangdao, Hebei, Peoples R China
来源
关键词
T2DM; sarcopenia; SMI; elderly; diagnosis; BONE-MINERAL DENSITY; LOW VITAMIN-D; MASS; OBESITY; WOMEN;
D O I
10.3389/fendo.2023.1083722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeTo determine an alternative skeletal muscle index (a-SMI), easy diagnosis of sarcopenia in elderly patients with type 2 diabetes mellitus (T2DM). Patients and methodsThis cross-sectional study included 223 inpatients with T2DM (100 males, age range 60-89; 123 females, age range 60-87). Screening for grip strength and gait speed, measuring SMI by dual-energy X-ray absorptiometry (d-SMI) for sarcopenia diagnosis, according to the Asian Working Group for Sarcopenia (AWGS) 2019 consensus. The a-SMI was established by binary logistic regression analysis with positive screening population. To assess the conformance of the new diagnostic approach with the AWGS 2019. ResultsSarcopenia was present in 36.3% of the study population. 59 had normal d-SMI and 81 had low d-SMI in screening patients with probable sarcopenia. In univariate analyses for all positive screening population, body mass index (BMI), 25-hydroxyvitamin D (25 - (OH) VitD), high density lipoprotein cholesterol (HDL-C), hypertension (HTN), and gender were correlates of d-SMI. Binary logistic regression analysis revealed that male (B = 2.463, 95%CI: 3.640 similar to 37.883, p = 0.000), HTN (B = 1.404, 95%CI: 1.599 similar to 10.371, p = 0.003), BMI (B = -0.344, 95%CI: 0.598 similar to 0.839, p = 0.000), 25-(OH) VitD (B = -0.058, 95%CI: 0.907 similar to 0.982, p = 0.004) were independent factors for d-SMI detection. Based on the extracted four correlates, the a-SMI was determined. The area under receiver operating characteristic (ROC) curve was 0.842, sensitivity and specificity for the new diagnostic approach were 84.0% and 84.5%. In a statistical measure of agreement between the AWGS 2019 and the new diagnostic approach, the kappa coefficient was 0.669 (p < 0.001). ConclusionThe a-SMI - based on gender, obesity status, 25-(OH) VitD, and HTN history - can be used in the absence of the d-SMI to supplement the algorithm for sarcopenia diagnosis in elderly patients with T2DM.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Deprescription in elderly patients with type 2 diabetes mellitus
    Silverii, Giovanni Antonio
    Caldini, Eleonora
    Dicembrini, Ilaria
    Pieri, Maria
    Monami, Matteo
    Mannucci, Edoardo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [32] Study of Fat and Energy Metabolism in Liver and Skeletal Muscle in Patients with Type 1 Diabetes mellitus
    Wolf, Peter
    Fellinger, Paul
    Pfleger, Lorenz
    Smajis, Sabina
    Beiglboeck, Hannes
    Gajdosik, Martin
    Andwerwald, Christian-Heinz
    Trattnig, Siegfried
    Luger, Anton
    Winhofer, Yvonne
    Krssak, Martin
    Krebs, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 353 - 353
  • [33] The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus
    Sarodnik, C.
    Bours, S. P. G.
    Schaper, N. C.
    van den Bergh, J. P.
    van Geel, T. A. C. M.
    MATURITAS, 2018, 109 : 70 - 77
  • [34] A nomogram for screening sarcopenia in Chinese type 2 diabetes mellitus patients
    Yu, Mingzhong
    Pan, Min
    Liang, Yebei
    Li, Xiaoling
    Li, Jingyan
    Luo, Li
    EXPERIMENTAL GERONTOLOGY, 2023, 172
  • [35] Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
    Petersen, KF
    Shulman, GI
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (5A): : 11G - 18G
  • [36] Association between skeletal muscle mass and insulin secretion in patients with type 2 diabetes mellitus
    Shishikura, Kanako
    Tanimoto, Keiji
    Sakai, Satoshi
    Tanimoto, Yoshimi
    Terasaki, Jungo
    Hanafusa, Toshiaki
    ENDOCRINE JOURNAL, 2014, 61 (03) : 281 - 287
  • [37] Insulin treatment increases skeletal muscle fibre area in patients with diabetes mellitus type 2
    Cederholm, T
    Sylvén, C
    Esbjörnsson-Liljedahl, M
    Jansson, E
    CLINICAL PHYSIOLOGY, 2000, 20 (05): : 354 - 359
  • [38] Leptin and NGF in saliva of patients with diabetes mellitus type 2: A pilot study
    Tvarijonaviciute, Asta
    Castillo, Candela
    Ceron, Jose J.
    Martinez-Subiela, Silvia
    Tecles, Fernando
    Lopez-Jornet, Pia
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2017, 46 (09) : 853 - 855
  • [39] Pilot study in pharmacogenomic management of empagliflozin in type 2 diabetes mellitus patients
    Jamalizadeh, Mahdieh
    Hasanzad, Mandana
    Sarhangi, Negar
    Sharifi, Farshad
    Nasli-Esfahani, Ensieh
    Larijani, Bagher
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2021, 20 (02) : 1407 - 1413
  • [40] Relationship between sarcopenia and fatty liver in middle-aged and elderly patients with type 2 diabetes mellitus
    Quan, Li
    Zhang, Fang
    Xu, Jing
    Wang, Fei
    Fan, Yong
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01)